![A Randomized, Multicenter, Double-Blind, Placebo-Controlled, 3 × 3 Factorial Design, Phase II Study to Evaluate the Efficacy and Safety of the Combination of Fimasartan/Amlodipine in Patients With Essential Hypertension]()
A Randomized, Multicenter, Double-Blind, Placebo-Controlled, 3 × 3 Factorial Design, Phase II Study to Evaluate the Efficacy and Safety of the Combination of Fimasartan/Amlodipine in Patients With Essential HypertensionLee, Hae-Young; Kim, Yong-Jin; Ahn, Taehoon; Youn, Ho-Joong; Chull Chae, Shung; Seog Seo, Hong; Kim, Ki-Sik; Rhee, Moo-Yong; Choi, Dong-Ju; Kim, Jae-Joong; Chun, Kook-Jin; Yoo, Byung-Su; Park, Jong-Seon; Oh, Seok-Kyu; Kim, Dong-Soo; Kwan, Jun; Ahn, Youngkeun; Bae Park, Jeong; Jeong, Jin-ok; Hyon, Min-Soo; Cho, Eun-Joo; Han, Kyoo-Rok; Kim, Doo-Il; Joo, Seung-Jae; Shin, Jin-Ho; Sung, Ki-Chul; Jeon, Eun-Seok · Clinical Therapeutics · 2015